Jushi Holdings (JUSHF) Other Non Operating Income (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Other Non Operating Income of $534000.0 for Q2 2026, down 87.87% year-over-year from $4.4 million in Q2 2025, and up 111.52% quarter-over-quarter from -$4.6 million in Q1 2026.
Jushi Holdings (JUSHF) Other Non Operating Income (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Other Non Operating Income for 6 consecutive years, with $534000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non Operating Income fell 87.87% year-over-year to $534000.0; the TTM figure through Jun 2026 stood at -$9.9 million (down 180.73% YoY), while the FY2025 annual figure was $7.5 million, up 19.17% from the prior year.
- Other Non Operating Income climbed to $534000.0 in Q2 2026 per JUSHF's latest filing, from -$4.6 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $42.6 million in Q2 2022 and bottomed at -$7.5 million in Q3 2023.
- Historically, Other Non Operating Income has averaged $5.8 million across 5 years, with a median of $2.9 million in 2024.
- Annual changes were most pronounced in 2024 — Other Non Operating Income surged 387.34% — and 2025, when it plunged 340.68%.
- Jushi Holdings' Other Non Operating Income stood at $28.7 million in 2022, then tumbled by 73.12% to $7.7 million in 2023, then tumbled by 72.88% to $2.1 million in 2024, then sank by 76.74% to $486000.0 in 2025, then rose by 9.88% to $534000.0 in 2026.
- Business Quant data shows JUSHF's Other Non Operating Income at $534000.0 in Q2 2026, -$4.6 million in Q1 2026, and $486000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 534,000.00 |
| Mar 31, 2026 | -4.64 Mn |
| Dec 31, 2025 | 486,000.00 |
| Sep 30, 2025 | -6.33 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 3.20 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | 2.63 Mn |
| Jun 30, 2024 | 5.31 Mn |
| Mar 31, 2024 | -5.10 Mn |
| Dec 31, 2023 | 7.70 Mn |
| Sep 30, 2023 | -7.46 Mn |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 8.03 Mn |
| Dec 31, 2022 | 28.65 Mn |
| Sep 30, 2022 | 6.35 Mn |
| Jun 30, 2022 | 42.57 Mn |
| Mar 31, 2022 | 14.31 Mn |
| Dec 31, 2021 | 38.37 Mn |
| Sep 30, 2021 | 55.06 Mn |